Eosinophilia during natalizumab treatment: Incidence, risk factors and temporal patterns. Keshvari MK, van Someren F, Sheikh S, Galea I, et al. J Neuroimmunol 2021;361:577729.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Keshvari MK, van Someren F, Sheikh S, Galea I, et al. Eosinophilia during natalizumab treatment: Incidence, risk factors and temporal patterns. J Neuroimmunol 2021;361:577729.
PMID: 34624660